About one in five older cancer patients report experiencing financial toxicity, according to researchers from the University of Rochester in New York. In a large cohort of more than 500 patients aged 70 years and older, 18% stated they were experiencing financial problems related to the cost of their treatment and that this was taking… Read More »Financial Toxicity Prevalent In Older Cancer Patients.
Research focused on long-term health problems after exposure to pollution will be in the spotlight at the upcoming European Respiratory Society (ERS) International Congress 2018. Mina Gaga “There are quite a lot of interesting data coming out about pollution and the lungs,” said ERS President Mina Gaga, MD, PhD, from Athens Chest Hospital in Greece.… Read More »Health Effects Of Pollution In The Air At ERS 2018
SANAA/HODEIDAH, Yemen (Reuters) – On Yemen’s western coast, Mohammed al-Hosami receives support from the people of his village in al Mahwit to pay for his mother’s cancer treatment in a clinic in nearby Hodeidah city. “There is no work or salary so we can’t afford transportation costs, and the village helped me with the payments… Read More »Cancer Patient Other Victim of Yemen’s War
Harvoni (ledipasvir / sofosbuvir) Myhep Lvir, Hepcinat, Ledihep, etc Epclusa (velpatasvir / sofosbuvir) Mylan All, Velpanat, Sovihep, Resof, etc. Treats hepatitis C. Harvoni (ledipasvir / sofosbuvir) is a combination pill for hepatitis C that you only need to take once a day. Depending on the amount of liver damage you have, it’s sometimes taken together… Read More »Compare Harvoni vs. Epclusa
An audit of death certificates from Norway has found that one third of all deaths attributed to prostate cancer were actually caused by something else. However, there was also an underreporting of prostate deaths in the study — wherein some men who were reported to have died of other causes were considered by the researchers… Read More »Did They Die Of Prostrate Cancer
Postmastectomy pain syndrome is a “major clinical challenge,” but four treatment modalities have been found to have a “significant effect” on the pain, conclude the authors of a new review systematic review of the subject. However, another expert laid emphasis elsewhere, saying there is “no magic drug” and that some patients feel their ongoing, intractable… Read More »Four Treatment For Mastectomy Pain,But ‘No Magic Drug’.
Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to the results of a major phase 3 chemoprevention trial from the United Kingdom, the Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia (AspECT) trial. Dr Janusz… Read More »Aspirin Plus PPI Prevents Esophageal Cancer.
For the management of early-stage follicular lymphoma (FL), a randomized trial shows that the combination of radiotherapy (RT) with chemo immunotherapy gives better clinical outcomes that treatment with radiation alone, and the researchers reporting these results say that they should change clinical practice. After a median follow-up of 9.6 years, the estimated 10-year progression-free survival… Read More »Combo Of RT And Chemotherapy: Best For Early FL
Adding the poly ADP ribose polymerase (PARP) inhibitor olaparib (Lynparza, AstraZeneca) to the androgen synthesis inhibitor abiraterone acetate (Zytiga, Janssen) significantly improves progression-free survival (PFS) in men with advanced prostate cancer over abiraterone alone, UK researchers have discovered. Studying 142 patients with metastatic castration-resistant prostate cancer (mCRPC), Dr Noel Clarke, The Christie and Salford Royal… Read More »Drug Combination Shows Promise In Advanced Prostrate Cancer.
For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018… Read More »Uveal Melanoma: Better Survival With Liver Directed Therapy.
Author: Nick Mulcahy The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer. The new product is pegfilgrastim-jmdb ( Fulphila , Mylan GmbH), approved for use to decrease the risk for infection in patients with nonmyeloid cancer who are receiving… Read More »FDA Approves Pegfilgrastim Biosimilar for Cancer Infection Risk
Patients with cancer are at a high risk for “financial toxicity,” and nurses need to be equipped to talk to them about the financial aspects of their care, according to Teresa Hagan Thomas, PhD, RN, from the University of Pittsburgh School of Nursing. It is not only the cost of treatment that contributes to financial… Read More »Financial Stress A Key Factor In Cancer Patient Care Plan.